Akebia Therapeutics
AKBA
#6962
Rank
$0.40 B
Marketcap
$1.94
Share price
4.02%
Change (1 day)
117.98%
Change (1 year)

Akebia Therapeutics (AKBA) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $0.25 Billion USD

According to Akebia Therapeutics's latest financial reports the company's total liabilities are $0.25 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Akebia Therapeutics - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.27 B-22.39%
2022-12-31$0.35 B-22.95%
2021-12-31$0.45 B14.83%
2020-12-31$0.39 B5.33%
2019-12-31$0.37 B4.39%
2018-12-31$0.36 B49.21%
2017-12-31$0.24 B4.13%
2016-12-31$0.23 B1843.53%
2015-12-31$11.94 M72.65%
2014-12-31$6.91 M76.91%
2013-12-31$3.91 M-20.58%
2012-12-31$4.92 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$83.35 B 32,723.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$60.08 B 23,559.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$108.12 B 42,478.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.26 B 3.82%๐Ÿ‡บ๐Ÿ‡ธ USA